IAM

At a glance

Iambic Therapeutics, Inc. (IAM) is listed on NASDAQ and classified in Biotechnology, part of the Healthcare sector. It is headquartered in San Diego, United States and has 171 employees. The company is worth $1.13B. The share price is 4.8% below its 52-week high of $25.00. None of the 38 superinvestors we track reported it in their latest 13F. Over the last 30 days, company insiders bought $11.5M of its stock on the open market and sold none.

Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.

Key metrics

Market cap

$1.13B

P/E

—

Forward P/E

—

P/B

—

Dividend yield

0.00%

Payout

—

EPS

-$2.69

ROE

—

Profit margin

0.00%

Revenue growth

+224.70%

Beta

—

52-week high

$25.00

52-week low

$16.15

Investors holding this

Major managers that reported this stock in their latest 13F.

None of the investors we track reported a position in IAM.

Others in the same sector

Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.

About the company